PLUR
Pluri Inc.
Key Financials
Revenue
$1.0M
↓ 24.0%
Gross Profit
$453000
↓ 30.7%
Operating Income
$-24938000
↓ 12.5%
Total Assets
$24.9M
↓ 35.7%
Cash & Equivalents
$3.5M
↓ 40.1%
EPS (Diluted)
$-2.44
↑ 31.5%
Shareholders' Equity
$-23036000.00
↓ 236.7%
Operating Cash Flow
$-19588000.00
↓ 7.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| S-1 | 10/6/2026 | View on SEC |
| S-3 | 9/11/2026 | View on SEC |
| S-8 | 9/11/2026 | View on SEC |
| S-8 | 9/11/2026 | View on SEC |
| 10-K | 9/10/2026 | View on SEC |
| D | 9/4/2026 | View on SEC |
| 424B5 | 8/28/2026 | View on SEC |
| 8-K | 8/28/2026 | View on SEC |
| 424B3 | 8/27/2026 | View on SEC |
| 4 | 8/24/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PLUR |
| Company Name | Pluri Inc. |
| CIK | 1158780 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | NV |
| Phone | 972-74-710-7171 |